$OMER $ACRS $RNA $EXEL $ZGNX IDRA may have huge upside as ph3 data from refractory melanoma of 450 patients expected any day from now. If ph3 is as good as ph2 then tilsotolimod [IDRA Drug] + ipilimumab[BMY drug] will become the SOC and huge-huge upside to the MC-l
1
1
1 Like